Fig. 1.
Fig. 1. Lymphocyte recovery in patients transplanted with either nonsorted autologous BM/PBSC or with FACS-sorted CD34+autologous HPC. Mean lymphocyte counts (±SD) in nine patients after treatment with marrow lethal therapy and infusion of the highly purified CD34+ HPC (○). The mean numbers (±SD) of lymphocytes in the blood of 20 patients receiving unmanipulated PBSC autografts (▵). The median time to obtaining an ALC > 500/μL among recipients of standard PBSC autografts was 20 days (range, 10 to 170) and was 30 days (range, 15 to 290) for the patients who received FACS sorted CD34+ HPC. The mean lymphocyte count in a separate population of 10 normal donor subjects was 1,800 cells/μL with a standard deviation of 400 cells/μL. Significant differences between the mean values in the two groups of patients are indicated: *P < .05; #P < .001.

Lymphocyte recovery in patients transplanted with either nonsorted autologous BM/PBSC or with FACS-sorted CD34+autologous HPC. Mean lymphocyte counts (±SD) in nine patients after treatment with marrow lethal therapy and infusion of the highly purified CD34+ HPC (○). The mean numbers (±SD) of lymphocytes in the blood of 20 patients receiving unmanipulated PBSC autografts (▵). The median time to obtaining an ALC > 500/μL among recipients of standard PBSC autografts was 20 days (range, 10 to 170) and was 30 days (range, 15 to 290) for the patients who received FACS sorted CD34+ HPC. The mean lymphocyte count in a separate population of 10 normal donor subjects was 1,800 cells/μL with a standard deviation of 400 cells/μL. Significant differences between the mean values in the two groups of patients are indicated: *P < .05; #P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal